141 related articles for article (PubMed ID: 21698811)
1. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
Wittmann T; Paradowski L; Ducrotté P; Bueno L; Andro Delestrain MC
Aliment Pharmacol Ther; 2010 Mar; 31(6):615-24. PubMed ID: 20003095
[TBL] [Abstract][Full Text] [Related]
3. [Meteospazmil for correction of motor disorders in functional colon diseases].
Agafonova NA; Iakovenko EP; Ivanov AN; Prianishnikova AS; Iakovenko AV
Eksp Klin Gastroenterol; 2009; (4):101-6. PubMed ID: 19961001
[TBL] [Abstract][Full Text] [Related]
4. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
Pace F; Maurano A; Ciacci C; Savarino V; Attili A; Iaquinto G; Magni E; Porro GB
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):155-62. PubMed ID: 20391952
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG
Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
7. Alverine citrate, simeticone, and Rome III irritable bowel syndrome.
Ford AC
Aliment Pharmacol Ther; 2010 Apr; 31(7):767-8; author reply 768-9. PubMed ID: 20415841
[No Abstract] [Full Text] [Related]
8. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
Bahar RJ; Collins BS; Steinmetz B; Ament ME
J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774
[TBL] [Abstract][Full Text] [Related]
9. On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.
Ducrotte P; Grimaud JC; Dapoigny M; Personnic S; O'Mahony V; Andro-Delestrain MC
Int J Clin Pract; 2014 Feb; 68(2):245-54. PubMed ID: 24147869
[TBL] [Abstract][Full Text] [Related]
10. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY; Lu CL; Chen CY; Luo JC
J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
[TBL] [Abstract][Full Text] [Related]
14. [Dynamics of clinical symptoms and indices of visceral sensitivity in patients with the irritated bowels syndrome treated with meteospasmyl].
Makarchuk PA; Golovenko OV; Mikhaĭlova TL; Podmarenkova LF
Eksp Klin Gastroenterol; 2005; (1):25-9. PubMed ID: 15991849
[No Abstract] [Full Text] [Related]
15. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
Johnston JM; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; O'Dea C; Baird M; Lembo AJ
Gastroenterology; 2010 Dec; 139(6):1877-1886.e2. PubMed ID: 20801122
[TBL] [Abstract][Full Text] [Related]
16. [Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].
Makarchuk PA
Eksp Klin Gastroenterol; 2007; (6):126-9. PubMed ID: 18418922
[No Abstract] [Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
[TBL] [Abstract][Full Text] [Related]
18. Visceral sensation and irritable bowel syndrome; with special reference to comparison with functional abdominal pain syndrome.
Nozu T; Okumura T
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():122-7. PubMed ID: 21443724
[TBL] [Abstract][Full Text] [Related]
19. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
20. [Complex therapy of patients with the irritable bowel syndrome].
Osipenko MF; Bikbulatova EA; Frolova NN; Loseva NV
Eksp Klin Gastroenterol; 2004; (5):39-44. PubMed ID: 15770859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
